New treatment for acute myelogenous leukemia.

New treatment for acute myelogenous leukemia.

Item
http://www.wikidata.org/entity/Q38284045
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted TherapyProgress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsDrugging the unfolded protein response in acute leukemiasAnti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous LeukemiaPhase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia.Involvement of calreticulin in cell proliferation, invasion and differentiation in diallyl disulfide-treated HL-60 cells.Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias.miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.Sophoraflavanone G Induces Apoptosis in Human Leukemia Cells and Blocks MAPK Activation.Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemia.
P2860

New treatment for acute myelogenous leukemia.

Item
http://www.wikidata.org/entity/Q38284045
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
New treatment for acute myelogenous leukemia.
@en
type
label
New treatment for acute myelogenous leukemia.
@en
prefLabel
New treatment for acute myelogenous leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
New treatment for acute myelogenous leukemia.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2015.981527
P407
P433
P478
P50
P577
P698